Russ Mould, Investment Director at stockbroker AJ Bell talks about the U.S. CPI Inflation figure out today, what it means for the market and whether banks are a good place to invest your money in a rising interest rate environment.

John Meyer, Mining analyst and partner at SP Angel talks about: Aex Gold #Aexg (Amaroq Minerals), BlueJay #JAY, Atlantic Lithium #ALL, Bluerock Diamonds #BRD, Rambler Metals & Mining #RMM & Pensana #PRE

Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", discusses whether crypto has lost its hype and if so could this lead to a longer, deeper bear market?

Alan Green CEO of Brand Communications talks about: Barclays #BARC, Amaroq Minerals (formerley AEX Gold) #AEXG & Sovereign Metals #SVML

John Meyer, Mining analyst and partner at SP Angel talks about China's lockdowns which are inciting factory violence, their dominance in rare earths plus: Amur Minerals #AMC, Atlantic Lithium #ALL & Pensana #PRE

Russ Mould, Investment Director at stockbroker AJ Bell talks about whether the Fed will blink if the stock market drops too much & what effect will China's economy opening back up, after they drop the zero covid policy, have on inflation?

Dan Lane, Head of Investment Writing at Freetrade discusses results from: Marks & Spencer #MKS, Pets at Home #PETS & Renewi #RWI

Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", talks about getting back into stocks as there maybe after we dicsuss that the inactivity in crypto may prove a money inflow for AIM.

Russ Mould, Investment Director at stockbroker AJ Bell asks the question: one stablecoin has been found out, which one is next? This follows volatility in the crypto market this week that centred around the demise of Terra (LUNA) which collapsed by more than 99%, wiping out the fortunes of crypto investors. LUNA has been compounded by issues with Terra’s dollar-pegged stablecoin UST.

Vadim Alexandre, Head of Healthcare at SP Angel discusses Final Results from e-Therapeutics #ETX a specialist in computational drug discovery with a focus on developing RNA interference ("RNAi") therapeutics.